APA (7th ed.) Citation

PKH, C., SP, H., JH, S., & AC, Y. (2024). Adjuvant therapy in hepatocellular carcinoma: The IMbrave050 trial - Authors' reply. Lancet (London, England), 404(10453), 657. https://doi.org/10.1016/S0140-6736(24)00801-8

Chicago Style (17th ed.) Citation

PKH, Chow, Hack SP, Spahn JH, and Yopp AC. "Adjuvant Therapy in Hepatocellular Carcinoma: The IMbrave050 Trial - Authors' Reply." Lancet (London, England) 404, no. 10453 (2024): 657. https://doi.org/10.1016/S0140-6736(24)00801-8.

MLA (9th ed.) Citation

PKH, Chow, et al. "Adjuvant Therapy in Hepatocellular Carcinoma: The IMbrave050 Trial - Authors' Reply." Lancet (London, England), vol. 404, no. 10453, 2024, p. 657, https://doi.org/10.1016/S0140-6736(24)00801-8.